December 19, 2018 — DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) today announced that after discussions with the U.S. Food and Drug Administration (FDA), its Biologics License Application (BLA) for Viaskin…Original Article
DBV Technologies Provides Update on Viaskin Peanut for Children Four to 11 Years of Age – BLA Withdrawn
